Advertisement
Advertisement

Beiersdorf acquires majority stake in S-Biomedic

By:
Reuters
Updated: Dec 16, 2022, 09:52 GMT+00:00

(Reuters) - Beiersdorf said on Friday it had acquired a majority stake in Belgian biotechnology company S-Biomedic NV.

Nivea tins on a production line at a Beiersdorf factory in Hamburg

(Reuters) – Beiersdorf said on Friday it had acquired a majority stake in Belgian biotechnology company S-Biomedic NV.

S Biomedic is to continue operating on its own under Beiersdorf’s existing microbiome programme, Beiersdorf added in a statement.

The purchase price was not disclosed.

(Reporting by Tristan Chabba in Gdansk, editing by Rachel More)

About the Author

Reuterscontributor

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:

Advertisement